Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
Blood Stem Cell Transplants Improve RRMS Patients' Disability, Phase 3 Trial Shows
Multiple Sclerosis News Today Blood stem cell transplants lead to significant improvements in relapsing-remitting multiple sclerosis patients' disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after … |
